Madrigal Pharmaceuticals, Inc. (MDGL) Social Stream



Madrigal Pharmaceuticals, Inc. (MDGL): $275.85

2.02 (+0.74%)

POWR Rating

Component Grades

Momentum

B

Stability

D

Sentiment

Quality

C

Add MDGL to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#115 of 168

in industry

MADRIGAL PHARMACEUTICALS INC (MDGL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MDGL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 11 $203 $145 $174.5 $278.41 -37.32%
2021-12-30 10 $203 $145 $173.714 $278.41 -37.6%
2022-02-25 9 $203 $131 $167.571 $278.41 -39.81%
2022-05-11 10 $203 $129 $161.5 $278.41 -41.99%
2022-05-12 10 $203 $129 $156.25 $278.41 -43.88%
2022-05-26 9 $203 $129 $156.25 $278.41 -43.88%
2022-08-04 9 $203 $75 $149.25 $278.41 -46.39%
2022-09-02 8 $203 $75 $149.25 $278.41 -46.39%
2022-11-10 7 $203 $75 $141.875 $278.41 -49.04%
2022-12-07 8 $203 $75 $141.875 $278.41 -49.04%
2022-12-20 11 $375 $92 $250.3 $278.41 -10.1%
2022-12-21 11 $375 $194 $289.75 $278.41 4.07%
2023-01-05 11 $390 $194 $296.25 $278.41 6.41%
2023-02-24 11 $390 $194 $303 $278.41 8.83%
2023-02-27 11 $390 $194 $305.083 $278.41 9.58%
2023-05-09 12 $390 $194 $312.583 $278.41 12.27%
2023-05-15 12 $396 $194 $319.833 $278.41 14.88%
2023-05-16 12 $396 $194 $324 $278.41 16.38%
2023-05-19 12 $396 $224 $326.5 $278.41 17.27%

The Trend in the Analyst Price Target


Over the past 36 months, MDGL's average price target has gone up $152.36.

Over the past 45 weeks, MDGL's average upside potential has been 43.89%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-07 8 203 75 141.875 67.36 110.62%
2023-01-05 11 390 194 296.250 271.71 9.03%
2023-02-08 11 390 194 303.000 259.92 16.57%
2023-05-07 12 390 194 312.583 306.37 2.03%
2023-05-19 12 396 224 326.500 276.61 18.04%

MDGL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 10 0 2 0 0 12

The Trend in the Broker Recommendations


Over the past 17 months, MDGL's average broker recommendation rating improved by 0.07.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MDGL as an investment opportunity.

  • MDGL has a greater average analyst price target than 2429.06% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MADRIGAL PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 163.95% of them.
  • In the context of stocks in the mid market cap category, MADRIGAL PHARMACEUTICALS INC's number of analysts covering the stock is greater than 1904.17% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, MADRIGAL PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1562.42% of them.

Stocks similar to MADRIGAL PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MGNX, CYRX, and CMRX.

Is MDGL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7886 seconds.